GIST Specialist for El Segundo, CA
A pathology report saying the margin is positive sounds like an unfinished operation. In gastrointestinal stromal tumors it frequently is not, and a second operation may add risk without adding benefit. Joshua Ellenhorn, MD, FACS reads the report and tells you which situation you are in.
- Second opinions on positive margin resections performed elsewhere
- Clinical Professor of Surgery, Cedars-Sinai Medical Center
- Reoperation recommended only where it adds benefit
- Thirty to forty minutes via Sepulveda or the 405
Positive Margin Does Not Automatically Mean Reoperation
In most cancer surgery a positive margin is a problem to be corrected. Residual microscopic disease at the edge of a specimen is a reservoir, and going back to clear it usually improves the odds. Patients and doctors alike carry that instinct into GIST, where it does not straightforwardly apply.
GIST behaves differently because it spreads differently. It is contained within a capsule, it rarely involves lymph nodes, and it does not infiltrate along tissue planes the way an adenocarcinoma does. Its recurrence risk is driven overwhelmingly by size, location, mitotic index and whether the tumor ruptured. A microscopically positive margin, in the absence of rupture, has not been shown to carry the same weight, and re-excision for that reason alone is not routinely recommended.
The distinction that does matter is rupture. A tumor whose capsule was breached, removed in fragments, or bleeding into the abdominal cavity has seeded the peritoneum, and that is a high risk situation regardless of what the margin says. Where an operative report is silent on capsule integrity, establishing what actually happened is more important than measuring the margin.
None of which means a second operation is never right. Where visible tumor was left behind, or where re-excision is technically straightforward and low risk, it can be entirely appropriate. The point is that it should follow from reasoning rather than from a word on a report.
Reading the Margin on Your Report
These are the standard designations and what each ordinarily leads to. The right response depends on the whole picture rather than the letter alone.
| Finding | What it means | Usual approach |
|---|---|---|
| R0 | No tumor at the margin microscopically | Complete resection. Risk grading and surveillance proceed on size, site and mitotic index |
| R1 | Tumor present microscopically at the margin, nothing visible | Re-excision not routinely recommended without rupture. Recalculate risk, consider adjuvant imatinib, set a surveillance schedule |
| R2 | Visible tumor left behind | Further surgery usually warranted, and medication considered first if it would make that operation smaller |
| Rupture documented | Capsule breached, piecemeal removal, or blood in the peritoneal cavity | Treated as high risk irrespective of margins. Long term targeted therapy and closer surveillance |
| Capsule status not stated | The report does not comment either way | Clarify before deciding anything. This determines how long you should be on medication |
| Margin unassessable | Specimen orientation or fragmentation prevented assessment | Effectively raises the same questions as rupture, and warrants a review of the operative findings |
Whatever the margin, the risk grading from size, site and mitotic index still has to be calculated. That number, not the margin, usually decides whether you need adjuvant therapy.
Why the Biology Justifies Restraint
GIST arises from the interstitial cells of Cajal, pacemaker cells inside the wall of the digestive tract that coordinate the contractions moving food along. It is a sarcoma, not a carcinoma, and almost every practical difference in how it is managed traces back to that.
Carcinomas travel through lymphatics. That is why gastric and colorectal cancer operations remove nodes and generous margins, and why a positive margin in those diseases is a genuine failure of clearance. GIST does not follow that route. It grows as a contained mass, spreads by seeding the peritoneum or reaching the liver through the bloodstream, and leaves nodes alone.
The consequence is that clearance is about the capsule rather than the centimetres around it. An intact tumor removed with a narrow margin is a good operation. A ruptured tumor removed with wide margins is not. That is the opposite of the intuition most surgical training builds, and it is why a second opinion on this specific question is worth having.
Three Things That Matter More Than the Margin
If your report says R1 and there was no rupture, these are the decisions actually worth making.
Recalculate the Risk
Size, site and mitotic index give a recurrence risk category. That number should be stated explicitly, and if nobody has calculated it, the treatment plan is being made without its most important input.
Decide on Adjuvant Therapy
Higher risk grading generally means around three years of imatinib, and mutation subtype determines whether standard dosing will work. This decision does far more for your outcome than clearing a microscopic margin.
Set a Surveillance Schedule
Defined imaging intervals with a stated endpoint, focused on the liver and peritoneal surfaces. Catching a recurrence at one centimetre rather than eight is worth more than any margin measured in millimetres.
How a Clean Resection Is Actually Achieved
Recordings of real GIST resections narrated by the surgeon who performed them. What determines the outcome is capsule handling, which these show directly.
Laparoscopic Resection of a Gastric GIST
A gastric GIST removed through small incisions with the capsule kept intact throughout.
Gastric GIST Resection: A Simplified Approach
A refined approach that shortens operating time without compromising specimen handling.
Robotic Resection of a Duodenal GIST
Duodenal GIST removed robotically with the pancreas and bile duct preserved.
Was the Capsule Intact?
Before discussing margins at all, establish whether the tumor came out whole. If the operative report does not say, that is the gap to close, because it matters considerably more than the millimetre at the edge.
Certifications and Appointments
Two American Board of Surgery certifications, a Cedars-Sinai teaching appointment, and membership of the societies whose guidelines address the margin question described above.
- American Board of Surgery, certified in General Surgery
- American Board of Surgery, certified in Colorectal Surgery
- California State Medical License
- Florida State Medical License
Joshua Ellenhorn, MD, FACS
Dr. Ellenhorn is a surgical oncologist and Clinical Professor of Surgery at Cedars-Sinai Medical Center, and a collaborative member of the Samuel Oschin Comprehensive Cancer Institute.
A meaningful part of this practice involves advising against operations. Reoperative abdominal surgery is genuinely harder than the first attempt, adhesions make the anatomy less predictable, and the morbidity is real. Recommending against a second operation when the evidence does not support it requires being confident enough in the disease to say so, and that confidence is what volume in a single tumor type actually buys.
He is certified by the American Board of Surgery in General Surgery and in Colorectal Surgery, a Fellow of the American College of Surgeons, and a member of the Society of Surgical Oncology and the American Society of Clinical Oncology. He practises with the Surgery Group of Los Angeles.
What Patients Say
Reviews left by patients treated by Dr. Ellenhorn at the Surgery Group of Los Angeles.
★★★★★The staff at the Surgery Group of Los Angeles are wonderful. They are kind, very attentive, the office is clean and I did not have to wait long at all. I cannot say enough great things about Dr. Ellenhorn. He is an excellent surgeon who is highly skilled and very knowledgeable. I cannot thank him enough for all he has done for my family and I.
Erika Frank
★★★★★I was very pleased with the office staff, they were always very pleasant and helpful. I was very impressed with Dr. Ellenhorn as well. He was very friendly and addressed all my concerns regarding my surgery and aftercare and follow up.
Terry Jackson
From El Segundo
Sepulveda Boulevard north to La Cienega, then east along 3rd Street, is usually the most predictable route and avoids the freeway entirely. The 105 east to the 405 north to the 10 is the faster option off peak. From the Douglas and Rosecrans side, Aviation to Sepulveda is the natural start. Allow thirty to forty minutes.
The office is in the medical plaza attached to Cedars-Sinai Medical Center. For the question on this page, most of what is needed is documents rather than tests, so a single visit with your operative report and pathology in hand is frequently enough to settle whether further surgery is warranted.
Patients travelling from outside the region, including Arizona and Nevada, can have reports reviewed remotely.
8635 W 3rd St, Suite 880W
Los Angeles, CA 90048
Monday to Saturday, 11:00am to 8:00pm
Closed Sunday
Frequently Asked Questions
My pathology says the margin is positive. Do I need another operation?
Why is GIST different from other cancers here?
What is the difference between R0, R1 and R2?
So what should happen if I have an R1 margin?
Does rupture change this?
Is a second operation risky?
Can you review an operation someone else performed?
How far is your office from El Segundo?
Before Agreeing to a Second Operation, Get It Reviewed.
A microscopically positive margin in GIST without rupture does not carry the weight it does in other cancers. Bring the operative report and pathology, and find out whether reoperation would actually add anything.
